Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
34th African Diaspora International Film Festival Opens with World Premiere of John Johnson Reporting
EIN Presswire
More than 70 films, three national Oscar submissions, acclaimed international cinema, and special programs celebrating the diversity of the African Diaspora.
MeiraGTx Reports Third Quarter 2026 Financial and Operational Results
GlobeNewswire, Inc.
Submission of Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP) expected in December 2026 Submission of full...
Kyverna Therapeutics Announces Completion of BLA Submission for Miv-cel in Stiff Person Syndrome and Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
BLA submission for miv-cel in SPS completed with request for priority review Commercial readiness advancing for potential U.S. launch of miv-cel, which would become the first approved therapy for SPS and first approved CAR-T therapy in autoimmune...
Theriva™ Biologics Reports Third Quarter 2026 Operational Highlights and Financial Results
GlobeNewswire, Inc.
– VIRAGE2 enrollment expected to complete in Q4 2026; initial data expected by Q3 2027 – – Company completes sale of SYN-004 (ribaxamase) and related portfolio of antibiotic-degrading enzymes to Biossil Labs Inc. in October, 2026 for $350,000...
Influential Women Profiles Elena Olson: Advancing Food Safety and Microbiome Science in Poultry Research
EIN Presswire
WI, UNITED STATES, November 12, 2026 /EINPresswire.com/ -- Research Scientist II at the University of Wisconsin–Madison, Elena Olson Combines Microbiology, Computational Biology, and Mentorship to Address Complex Challenges in Agriculture and...
Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights
GlobeNewswire, Inc.
Initiated Phase 1 study of AP03, a fixed dose combination of nebulized pirfenidone and nintedanib, in healthy volunteers Presented new AP01 data at ERS Congress and published detailed results from AP02 Phase 1 trials in Respiratory Research; data...
Nuwellis Reports Third Quarter 2026 Financial Results and Business Update Highlighted by 430 Basis Point Gross Margin Expansion and 13% Reduction in Operating Expenses, Driving 24% Improvement in Operating Loss
GlobeNewswire, Inc.
Console unit sales increased 88% year-to-date versus prior-year period, expanding its installed base to drive future recurring circuit revenue Advanced growth strategy with 510(k) submission for Aquadex label expansion and two product...
Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
GlobeNewswire, Inc.
Registrational U.S. AURORA Phase 3 clinical trial underway for denifanstat in moderate to severe acne, with topline data anticipated in the second half of 2027 Positive denifanstat Phase 3 clinical trial results in China from license partner...
Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update
GlobeNewswire, Inc.
Adjusted EBITDA of $0.22 million, improves $1.01 million year-over-year, operating loss narrows by 80% Proprietary products reach 31% of MyMedi.ca sales, up from 19%; QUIX™ launches with 10 SKUs TORONTO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Avicanna...
Satellos Reports Third Quarter 2026 Financial Results and Highlights Company Progress
GlobeNewswire, Inc.
BASECAMP Phase 2 topline data expected in Q1 2027 MRI-measured muscle fat fraction selected as the primary efficacy endpoint for BASECAMP Forazapadin cleared to begin clinical evaluation for FSHD in the U.S. and Canada; enrollment in Phase 2...
Traws Pharma Reports Final Phase 2a Results for Ratutrelvir in COVID-infected Subjects, Showing Fewer Treatment-Related Adverse Events and No Viral Rebounds Versus PAXLOVID®
GlobeNewswire, Inc.
Ratutrelvir, a once-daily, ritonavir-free oral antiviral therapy in development for COVID-19 infections, showed symptom resolution time comparable to PAXLOVID®, with no viral rebound through Day 28 and fewer treatment-related adverse events in...
Pharvaris Reports Third Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
Deucrictibant IR NDA under review by the FDA with PDUFA date of April 23, 2027 Topline data from part 1 of CREAATE, a pivotal Phase 3 study evaluating deucrictibant XR for the prophylaxis of AAE-C1INH attacks, expected in 1Q2027; enrollment...
Parabilis Medicines Reports Third Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire, Inc.
Presented updated Phase 1/2 data at ESMO Congress 2026 demonstrating a 72.2% objective response rate at the 32-week landmark and a favorable safety and tolerability profile for zolucatetide in desmoid tumors Reached alignment with the U.S. FDA on...
EyePoint Reports Third Quarter 2026 Financial Results and Provides Recent Corporate Developments
GlobeNewswire, Inc.
– Organizational focus on DURAVYUTM Phase 3 DME program; trials fully enrolled with topline data expected in early Q4 2027 – – DURAVYU DME program supported by the positive Phase 2 VERONA trial and multi-MOA activity blocking both VEGF and...
Cardiff Oncology Reports Third Quarter 2026 Results and Provides Business Update
GlobeNewswire, Inc.
Phase 2 trial remains ongoing, with median PFS not reached in the 30 mg onvansertib + FOLFIRI/bev arm versus median PFS of approximately 11 months in the combined SoC arms All patients remaining in the 30 mg onvansertib + FOLFIRI/bev arm have now...
Eikon Therapeutics Reports Third Quarter 2026 Financial Results and Provides Clinical Updates
GlobeNewswire, Inc.
Presented seven posters at the 2026 European Society for Medical Oncology (ESMO) Congress highlighting progress across the oncology portfolio, including clinical data from Eikon’s PARP1-selective inhibitor and Werner (WRN) helicase inhibitor...
Forging Ahead with Resolve Toward a Bright Future for the Asia-Pacific
Ministry of Foreign Affairs of the People's Republic of China
Keynote Speech by H.E. Xi Jinping President of the People’s Republic of China At the APEC CEO Summit Shenzhen, November 18, 2026 Distinguished Guests, Ladies and Gentlemen, Dear Friends, Good morning!
Fennec Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire, Inc.
~ Third Quarter 2026 Net Product Sales of $19.4 Million, Up 56% Year over Year ~ ~ Third Quarter 2026 Non-GAAP Adjusted EBITDA of $5.8 Million ~ ~ With $6.7 Million in Positive Cash Flow from Operations, Cash Position in the Third Quarter 2026...
DIAGEN AI, INC. PARTNERS WITH NASDAQ:MEDS TO DISCOVER NOVEL CANCER TARGETS & DEVELOP ANTI-CANCER PEPTIDE PIPELINE
EIN Presswire
DiaGen Earns 630,000 Share Equity Stake in Nasdaq:MEDS Equivalent to 9.9% of the Company valued currently at over USD $400,000 VANCOUVER, BC, CANADA, November 18, 2026 /EINPresswire.com/ -- DIAGEN AI, INC. PARTNERS WITH DATAMEDS AI (NASDAQ:MEDS)...
Long-term N addition shifts soil microbial community structure and potential carbon-nitrogen and PAH metabolic functions
EIN Presswire
GA, UNITED STATES, November 18, 2026 /EINPresswire.com/ -- A 15-year field experiment shows that long-term nitrogen fertilisation reshapes soil microbial networks and their genetic potential for carbon, nitrogen and PAH metabolism.
Sign up for:
Food & Beverage Report
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.